HLN:NYSEHaleon plc Analysis
Data as of 2026-09-12 - not real-time
$9.19
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Haleon plc trades at $9.19, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 9.1%. RSI sits at 29.3, which reads as oversold, and MACD momentum is bearish. Price has been bracketed by support at $9.10 and resistance at $10.26.
Multiples put this in undervalued territory: 18.8 times earnings against the sector's 29.5. Analyst price targets sit 30.5% above the current price. Revenue is growing at 2.2% on a 14.6% profit margin. The 2.14% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 20.4%, a beta of -0.07 and a maximum drawdown of 22.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
Multiples put this in undervalued territory: 18.8 times earnings against the sector's 29.5. Analyst price targets sit 30.5% above the current price. Revenue is growing at 2.2% on a 14.6% profit margin. The 2.14% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 20.4%, a beta of -0.07 and a maximum drawdown of 22.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
Top Market Events
Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of...Haleon stock trades slightly above its recent close as analysts highlight a cleaner second quarter,Haleon plc LSE:HLN has released its half-year 2026 results, publishing the full report through the London Stock...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- RSI at 29.3 signals oversold conditions
- Trading below the 200-day average of 9.84
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- RSI at 29.3 signals oversold conditions
- P/E of 18.8 versus sector average of 29.5
- Trading below the 200-day average of 9.84
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 18.8 versus sector average of 29.5
- Analyst targets imply +30.5% versus the current price
- Dividend yield of 2.14%
Key Metrics & Analysis
Financial Health
Revenue Growth2.20%
Profit Margin14.55%
P/E Ratio18.8
ROE10.09%
ROA5.08%
Debt/Equity50.20
P/B Ratio1.8
Op. Cash Flow$2.7B
Free Cash Flow$1.8B
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI29.3
Support$9.10
Resistance$10.26
MA 20$9.79
MA 50$9.85
MA 200$9.84
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14
Valuation
Fair Value$3.88
Target Price$11.99
Upside/Downside30.51%
GradeUndervalued
TypeBlend
Dividend Yield2.14%
Risk Assessment
Beta-0.07
Volatility20.38%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.